Evidence map›Paper›PMID 36985397›Full record

ArticleMolecules (Basel, Switzerland)2023

Selenium Nanoparticles Based on

Mengxin Yao, Yuan Deng, Zhimin Zhao, Depo Yang, Guohui Wan, Xinjun Xu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Preparation and In Vitro Bioactivity Evaluation ofFoods (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Phytofabrication of Selenium Nanoparticles withMolecules (Basel, Switzerland) · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mengxin YaoSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Yuan DengSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Zhimin ZhaoSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.ORCID 0000-0002-3384-2365
Depo YangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Guohui WanSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.ORCID 0000-0001-5170-7282
Xinjun XuSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Sun Yat-sen University · CN

Funding

Ministry of Science and Technology 2022YFD1600300The Innovation Team of Modern Agricultural Industrial 412 Technology System of Guangdong Province 2021KJ142, 2022KJ142
6 · The paper itself

Abstract

Recently, selenium nanoparticles have been drawing attention worldwide, and it is crucial to increase the stability of nano-Se.

Indexed as

MorindaNanoparticlesSeleniumAnimalsCytokinesMicePolysaccharidesCytokinesPolysaccharidesSeleniumanti-cancer activitiesimmune enhancementMorinda officinalis polysaccharidesselenium nanoparticles

Identifiers

PMID36985397
PMCPMC10052065
OpenAlexW4323362035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.